• Optimization of the manufacturing process, scale-up manufacturing until pilot plant synthesis (under GMP-like conditions)
• Determination of design space (QbD)
• Biocompatibility testing based on the gap analysis: in vitro biocompatibility assays under ISO10993 and based on Good Laboratory Practice (GLP) principles (such as cytotoxicity, systemic toxicity, rodent carcinogenicity, if required)